This company was established in 2018 in Ivory Coast with the aim of building a factory for the production of pharmaceutical materials and cosmetics, as well as all essential and vital supplementary products. It focuses on the purchase, sale, supply, and export of these products and medical promotion of related materials. The company’s capital is 2.5 Billion West African Francs, equivalent to 1.2 million Kuwaiti Dinars, with ACDIMA holding a 42.08% stake in the company's capital.
The company is completing the construction phase of the factory building, and efforts are underway to expedite the registration of the products in preparation for their market launch. The company’s unaudited financial results for 2022 showed losses of approximately 238 million West African Francs, equivalent to 116,620 Kuwaiti Dinars, compared to approximately 271 million West African Francs, equivalent to 132,790 Kuwaiti Finars, for 2021.